|
Originally published In Press as doi:10.1074/jbc.M106445200 on November 13, 2001
J. Biol. Chem., Vol. 277, Issue 4, 2916-2922, January 25, 2002
Scavenger Receptor Class B Type I Is Expressed in Cultured
Keratinocytes and Epidermis
REGULATION IN RESPONSE TO CHANGES IN CHOLESTEROL HOMEOSTASIS AND
BARRIER REQUIREMENTS*
Hiroki
Tsuruoka §¶,
Weerapan
Khovidhunkit **,
Barbara E.
Brown §,
Joachim W.
Fluhr §,
Peter M.
Elias §, and
Kenneth R.
Feingold§ **
From the Dermatology and Medical (Metabolism)
Services, Department of Veterans Affairs Medical Center, San Francisco,
California 94121, the Departments of § Dermatology and
** Medicine, University of California, San Francisco School
of Medicine, San Francisco, California 94143, and ¶ R & D
Department of Dermatological Science, POLA Laboratories, POLA
Chemical Industries Inc., 560 Kashio-cho, Totsuka-ku,
Yokohama 244-0812 Japan
Cholesterol is a key lipid in the
stratum corneum, where it is critical for permeability barrier
homeostasis. The epidermis is an active site of cholesterol synthesis,
but inhibition of epidermal cholesterol synthesis with topically
applied statins only modestly affects epidermal permeability barrier
function, suggesting a possible compensatory role for extraepidermal
cholesterol. Scavenger receptor class B type I (SR-BI) is a recently
described cell surface receptor for high density lipoproteins (HDL)
that mediates the selective uptake of cholesterol esters from
circulating HDL. In the present study, we demonstrate that SR-BI is
present in cultured human keratinocytes and that calcium-induced
differentiation markedly decreases SR-BI levels. Additionally, the cell
association of [3H]cholesterol-labeled HDL
decreased in differentiated versus undifferentiated keratinocytes. Furthermore, the inhibition of cholesterol synthesis with simvastatin resulted in a 3-4-fold increase in both SR-BI mRNA and protein levels, whereas conversely, addition of
25-hydroxycholesterol suppressed SR-BI levels by approximately 50%.
SR-BI mRNA is also expressed in murine epidermis, increasing by
50% in parallel with cholesterol requirements following acute barrier
disruption. Because the increase is completely blocked by occlusion
with a vapor-impermeable membrane, changes in epidermal SR-BI
expression are regulated specifically by barrier requirements. Lastly,
using immunofluorescence we demonstrated that SR-BI is present in human
epidermis predominantly in the basal layer and increases following
barrier disruption. In summary, the present study demonstrates first
that SR-BI is expressed in keratinocytes and regulated by cellular
cholesterol requirements, suggesting that it plays a role in
keratinocyte cholesterol homeostasis. Second, the increase in SR-BI
following barrier disruption suggests that SR-BI expression increases
to facilitate cholesterol uptake leading to barrier restoration.
*
This work was supported by National Institutes of Health
Grants HD 29706, AR 39639, AR 29706, and PO039448 and by Veterans Affairs Research Funding.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Metabolism Section,
Dept. of Veterans Affairs Medical Center, 4150 Clement St., Box 111F,
San Francisco, CA 94121. Tel.: 415-750-2005; Fax: 415-750-6927; E-mail: kfngld@itsa.ucsf.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. W. Zhang and N. A. Monteiro-Riviere
Mechanisms of Quantum Dot Nanoparticle Cellular Uptake
Toxicol. Sci.,
July 1, 2009;
110(1):
138 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Juan, M. M. Veniant, J. Helmering, P. Babij, D. M. Baker, M. A. Damore, M. B. Bass, T. Gyuris, M. Chhoa, C.-M. Li, et al.
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice
J. Lipid Res.,
March 1, 2009;
50(3):
534 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimura, C. Mogi, H. Tomura, A. Kuwabara, D.-S. Im, K. Sato, H. Kurose, M. Murakami, and F. Okajima
Induction of Scavenger Receptor Class B Type I Is Critical for Simvastatin Enhancement of High-Density Lipoprotein-Induced Anti-Inflammatory Actions in Endothelial Cells
J. Immunol.,
November 15, 2008;
181(10):
7332 - 7340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Feingold
Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis
J. Lipid Res.,
December 1, 2007;
48(12):
2531 - 2546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. J. Jiang, B. Lu, P. Kim, P. M. Elias, and K. R. Feingold
Regulation of ABCA1 expression in human keratinocytes and murine epidermis
J. Lipid Res.,
October 1, 2006;
47(10):
2248 - 2258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Khovidhunkit, J. P. Hachem, K. F. Medzihradszky, P. N. Duchateau, J. K. Shigenaga, A. H. Moser, I. Movsesyan, J. Naya-Vigne, J. P. Kane, K. R. Feingold, et al.
Parotid secretory protein is an HDL-associated protein with anticandidal activity
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2005;
288(5):
R1306 - R1315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Treguier, C. Doucet, M. Moreau, C. Dachet, J. Thillet, M. J. Chapman, and T. Huby
Transcription Factor Sterol Regulatory Element Binding Protein 2 Regulates Scavenger Receptor Cla-1 Gene Expression
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2004;
24(12):
2358 - 2364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, M. Parsons, X. Zhou, A. C. Nicholson, A. M. Gotto Jr, and D. P. Hajjar
Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104)
Circulation,
November 30, 2004;
110(22):
3472 - 3479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. O'Connell, M. Denis, and J. Genest
Cellular Physiology of Cholesterol Efflux in Vascular Endothelial Cells
Circulation,
November 2, 2004;
110(18):
2881 - 2888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Sposito, S. Gonbert, E. Bruckert, M. Atassi, I. Beucler, S. Amsellem, O. Khallouf, P. Benlian, and G. Turpin
Magnitude of HDL Cholesterol Variation After High-Dose Atorvastatin Is Genetically Determined at the LDL Receptor Locus in Patients With Homozygous Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2003;
23(11):
2078 - 2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rigotti, H. E. Miettinen, and M. Krieger
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
Endocr. Rev.,
June 1, 2003;
24(3):
357 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Imachi, K. Murao, W. Cao, S. Tada, T. Taminato, N. C.W. Wong, J. Takahara, and T. Ishida
Expression of Human Scavenger Receptor B1 on and in Human Platelets
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2003;
23(5):
898 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Panzenboeck, Z. Balazs, A. Sovic, A. Hrzenjak, S. Levak-Frank, A. Wintersperger, E. Malle, and W. Sattler
ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells
J. Biol. Chem.,
November 1, 2002;
277(45):
42781 - 42789.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|